Clinically Isolated Syndrome (CIS) Market is segmented By Treatment (Systemic Treatments, Primary Therapy, Primary Therapy, Recurrence Therapy, Recurrence Therapy), By Emerging Drugs, (Olvimulogene nanivacirepvec, Rucaparib), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.
The major players operating in the Clinically Isolated Syndrome (CIS) Market include NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Siemens Healthcare Private Limited, Natus Medical Incorporated, and Compumedics Limited.
Clinically Isolated Syndrome (CIS) Market